Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Burkitt Lymphoma 4Recurrence 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Hematologic Neoplasms 3Neuroblastoma 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Transplant-Related Hematologic Malignancy 1Teratoma 1Sarcoma 1Rhabdomyosarcoma 1Primary Myelofibrosis 1Neoplasms by Histologic Type 1Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 15venetoclax 11fludarabine 10Cytarabine 10Mycophenolic Acid 6Azacitidine 6fludarabine phosphate 5Daunorubicin 5Busulfan 5ruxolitinib 4ponatinib 4blinatumomab 4Whole-Body Irradiation 4Vincristine 4Tacrolimus 4Rituximab 4Methotrexate 4Dexamethasone 4asciminib 3Mercaptopurine 3Inotuzumab Ozogamicin 3Granulocyte Colony-Stimulating Factor 3Cyclosporine 3revumenib 2quizartinib 2pegaspargase 2nilotinib 2ibrutinib 2Thioguanine 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Leukemia × Granulocyte Colony-Stimulating Factor × 90 days × Clear all
NCT03434730 2026-05-26

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
46 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT06001788 2026-04-14

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Kura Oncology, Inc.

Phase 1 Recruiting
171 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT07044544 2026-03-04

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

University of Alabama at Birmingham

Phase 1 Recruiting
20 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡